Chapter 2 - Neoplasms (C00-D49)»Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)»Juvenile myelomonocytic leukemia, not having achieved remission (C93.30)
C93.30
Juvenile myelomonocytic leukemia, not having achieved remission
Related indications (MeSH) (1)
Leukemia, Myelomonocytic, Juvenile61 drugs (45 approved, 16 experimental)
A leukemia affecting young children characterized by SPLENOMEGALY, enlarged lymph nodes, rashes, and hemorrhages. Traditionally classed as a myeloproliferative disease, it is now considered a mixed myeloproliferative-mylelodysplastic disorder.